BioSpace News Archive

Aptevo Therapeutics Inc. today announced that the peer-reviewed journal Cancers published results of the Company’s research on mitigation of the risk of cytokine release syndrome (CRS) as well as its effective management in patients with acute myeloid leukemia (AML)

Emmaus Life Sciences, Inc. (OTC: EMMA) a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today announced the submission of its application for marketing authorization of Endari® to the United Arab Emirates (U.A.E.) Ministry of Health.

180 Life Sciences Corp. today announced that its pre-clinical study report on the effects of CBG (cannabigerol) derivatives on pain, inflammation and obesity was published in the journal Molecules.

Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that GlaxoSmithKline (NYSE: GSK) has purchased an additional Beacon™ Optofluidic system to expand its antibody therapeutics capacity.

Anixa Biosciences, Inc. (NASDAQ: ANIX) (“Anixa”) announced today that, in conjunction with its partner, Cleveland Clinic, it has commenced dosing of patients for a novel study of its vaccine that is being investigated for preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.

BlueWillow Biologics, Inc. today announced that the company will present positive interim data from its phase 1 clinical trial of a novel intranasal anthrax vaccine at a Lightning Talks Session of BARDA’s Industry Day, November 3 and 4, 2021.

Novozymes delivered 7% organic sales growth in the third quarter and 6% organic sales growth in the first nine months of 2021.

Mindset Pharma Inc. today announced that it will participate in Microdose’s Wonderland: Miami to be held at the Adrienne Arsht Center for the Performing Arts in Miami, FL on November 8-9